• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GERMANY ARCHITECT ANTI-HCV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GERMANY ARCHITECT ANTI-HCV Back to Search Results
Catalog Number 06C37-78
Device Problem False Positive Result (1227)
Patient Problem Misdiagnosis (2159)
Event Date 03/29/2019
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
A clinician questioned repeat (b)(6) architect anti-hcv results generated for a (b)(6) year old male dailysis patient on (b)(6) 2019 and (b)(6) 2019.Based on the (b)(6) results, the clinician assigned the patient to the (b)(6) patient group and performed dialysis.Elisa anti-hcv and (b)(6) rna testing was (b)(6), so the clinician suspected the architect results to be (b)(6).The patient was tested again on (b)(6) 2019 and the anti-hcv result was (b)(6).The patient was exposed to (b)(6) dialysis equipment.No post-dialysis (b)(6) testing was provided.Since it is unknown when the last exposure to the (b)(6) dialysis equipment was, it cannot be ruled out that an adverse event / serious injury may have occurred.
 
Manufacturer Narrative
Historical quality metrics were reviewed and no adverse trend was identified for the customer's issue.Historical lot specific search could not be performed since the lot number used by the customer is unknown.Field data was used to evaluate the number of standard deviations to the cut-off for the negative population tested with the architect anti-hcv assay.The number of standard deviations to the cutoff for the negative population tested are within the established limits or above which is even a better performance.The initial reactive rate by time was reviewed for the last 6 months.The initial reactive rate was within established limits or below the limit.A review of labeling concluded that the issue is sufficiently addressed in the labeling.Based on the available information, no product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT ANTI-HCV
Type of Device
ANTI-HCV
Manufacturer (Section D)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key8823603
MDR Text Key152936181
Report Number3002809144-2019-00467
Device Sequence Number1
Product Code MZO
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 09/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/24/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number06C37-78
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received09/03/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER; ARCHITECT I2000SR ANALYZER; LIST 03M74-02, SERIAL (B)(4); LIST 03M74-02, SERIAL (B)(4)
Patient Outcome(s) Other;
Patient Age59 YR
-
-